Pricing
BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Full screen
Thomas M. Loarie
View all
9 people · 0 jobs
6 people · 0 jobs
5 people · 0 jobs
HQ
0 people · 0 jobs
Gilead Sciences
174 followers
Regeneron
144 followers
Illumina
82 followers
Agilent Technologies
90 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
50 followers
GRAIL
32 followers
Cytiva
20 followers
PerkinElmer
13 followers
Editas Medicine
5 followers
Organogenesis
Explore companies